Sustainability
Sustainability reporting is increasingly recognized as both important and strategically
beneficial for life sciences companies. While it's not yet a global legal mandate, the trend is moving toward mandatory Environmental, Social, and Governance (ESG) and
sustainability disclosure, with voluntary reporting already strongly encouraged by investors
and customers
In the European Union, sustainability reporting has become mandatory for many life sciences
companies under the Corporate Sustainability Reporting Directive (CSRD)
The CSRD requires in-scope companies, including large life sciences and biotech firms, to prepare detailed sustainability reports covering:
-
Environmental impact (including climate change, resource use, pollution, and biodiversity)
-
Social factors (employee rights, diversity, and community engagement)
-
Governance (business ethics and risk management)
-
Supply chain transparency
-
Double materiality (both the impact of sustainability matters on the company and the company's impact on society and the environment)
Companies must report in accordance with the European Sustainability Reporting Standards
(ESRS), and the requirements are being phased in, with additional
sector-specific standards expected by 2026
Life sciences organizations face unique sustainability challenges due to industry specifics such as:
-
Compute-intensive processes for research, genomic analysis, and molecular modeling
-
Long-term data retention requirements for regulatory adherence
-
High-performance computing needs for drug discovery and clinical analysis
-
Large-scale data collection and processing from laboratory instruments
-
Global collaboration requirements across research sites and clinical trials
Focus areas
